Aim ImmunotechAIM
13F holders, Q1 2026 (March 31)18holders +5
7new positions
2sold out
$0.58avg. 13F price*
At the end of Q1 2026, 18 institutions reported holding Aim Immunotech Inc. (AIM) in their 13F filings, up 5 from Q4 2025. 7 opened new positions and 2 sold out. The largest holders were Virtu Financial LLC ($30K), Geode Capital Management, LLC ($18K) and HRT Financial LP ($15K).
- Company
- Aim Immunotech Inc.
- CUSIP
- 00901B303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $72K |
| Exits | 2 | $79K |
All 13F filers, Q4 2025 → Q1 2026: 139,711 shares bought and 69,951 shares sold, net +69,760 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Virtu Financial LLC | 0.00% | New | 50,895 | $30K |
| Geode Capital Management, LLC | 0.00% | Add +72.2% | 29,918 | $18K |
| HRT Financial LP | 0.00% | New | 26,032 | $15K |
| XTX Topco Ltd | 0.00% | New | 20,590 | $12K |
| Jane Street Group, LLC | 0.00% | New | 20,047 | $12K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 17,519 | $10K |
| NewEdge Advisors, LLC | 0.00% | New | 5,000 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +3634.4% | 4,668 | $3K |
| Morgan Stanley | 0.00% | No change | 864 | $505 |
| Community Bank, N.A. | 0.00% | No change | 132 | $76 |
| Harbour Investments, Inc. | 0.00% | New | 32 | $19 |
| Creative Financial Designs Inc. | 0.00% | New | 30 | $18 |
| Osaic Holdings, Inc. | 0.00% | No change | 15 | $7 |
| Hoey Investments, Inc. | 0.00% | No change | 10 | $6 |
| UBS Group AG | 0.00% | Reduce -99.7% | 1 | $1 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 2 | $1 |
| Farther Finance Advisors, LLC | 0.00% | No change | 1 | $1 |
| Intesa Sanpaolo Wealth Management | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is AIM's weight in each manager's 13F, not the share of Aim Immunotech Inc. the manager owns.